Protalix BioTherapeutics (PLX) Liabilities from Discontinued Operations (2014 - 2016)

Protalix BioTherapeutics' Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 293000.0 for Q2 2016.

• In Q2 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 293000.0; the TTM figure through Jun 2016 stood at 293000.0 (changed N/A YoY), while the FY2015 annual figure was 1568000.0, down 97.03% from the prior year.
• Liabilities from Discontinued Operations for Q2 2016 stood at 293000.0, up from 128000.0 in the prior quarter.
• The five-year high for Liabilities from Discontinued Operations was 52830000.0 in Q4 2014, with the low at 128000.0 in Q1 2016.
• The 3-year median for Liabilities from Discontinued Operations is 930500.0 (2015), against an average of 13704750.0.
• Peak annual rise in Liabilities from Discontinued Operations reached 97.03% in 2015, while the deepest fall reached 97.03% in 2015.
• Protalix BioTherapeutics' Liabilities from Discontinued Operations stood at 52830000.0 in 2014, then tumbled by 97.03% to 1568000.0 in 2015, then slumped by 81.31% to 293000.0 in 2016.
• Business Quant data shows PLX's Liabilities from Discontinued Operations at 293000.0 in Q2 2016, 128000.0 in Q1 2016, and 1568000.0 in Q4 2015.